Hidradenitis suppurativa flares following COVID-19 vaccination: A case series

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series

Bibliographic Details
Main Authors:	Fabrizio Martora, MD, Vincenzo Picone, MD, Gabriella Fabbrocini, Prof, Claudio Marasca, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-05-01
Series:	JAAD Case Reports
Subjects:	COVID-19 IHS4 hidradenitis suppurativa vaccine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622001357

Similar Items

Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review
by: Angelo Ruggiero, et al.
Published: (2022-02-01)

Multimodal management of hidradenitis suppurativa
by: Gregor B.E. Jemec, MD, DMSc
Published: (2020-06-01)

Hidradenitis Suppurativa-An intractable Dermo- Surgical Disease
by: Muhammad Ateeq
Published: (2012-12-01)

Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging Association
by: Martora F, et al.
Published: (2025-01-01)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
by: Emanuele Scala, et al.
Published: (2021-08-01)

Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report
by: Angelo Ruggiero, et al.
Published: (2023-02-01)

Gender differences in hidradenitis suppurativa characteristics: A retrospective cohort analysis
by: Terri Shih, BS, et al.
Published: (2021-12-01)

Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature
by: Fabrizio Martora, et al.
Published: (2024-09-01)

Response to “Hidradenitis suppurativa electronic medical record (EPIC) tool: A convenient tool of hidradenitis suppurativa specialty clinics”
by: Terri Shih, MD, et al.
Published: (2025-04-01)

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
by: Martora F, et al.
Published: (2024-01-01)

Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
by: Napolitano M, et al.
Published: (2017-04-01)

Intermammary Hidradenitis Suppurativa: A Case Report
by: Dharmadji HP, et al.
Published: (2022-04-01)

Hidradenitis suppurativa in a long-lived patient with trisomy 13
by: Nobuko Tabata, MD, PhD, et al.
Published: (2020-06-01)

Ectopic hidradenitis suppurativa on the dorsal foot of a road maker
by: Angelique Rondags, MD, et al.
Published: (2017-09-01)

Use of topical clascoterone for the treatment of hidradenitis suppurativa
by: Kaitlynne N. Cunningham, BS, et al.
Published: (2023-06-01)

Immunisation status during biologic therapy for hidradenitis suppurativa and psoriasis
by: Corey Stone, et al.
Published: (2023-09-01)

Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series
by: Federica Repetto, et al.
Published: (2022-09-01)

Radiation-induced hidradenitis suppurativa: A case report
by: Roger Haber, MD, et al.
Published: (2017-05-01)

De novo ectopic hidradenitis suppurativa versus classic ectopic hidradenitis suppurativa: A case series and review of the literature
by: Cassidy M. Nguyen, BS, et al.
Published: (2024-11-01)

Lymphangioma circumscriptum as an untoward consequence of hidradenitis suppurativa surgery
by: Molly R. Marous, MD, et al.
Published: (2021-09-01)

The Clinical Relevance of the Microbiome in Hidradenitis Suppurativa: A Systematic Review
by: Dillon Mintoff, et al.
Published: (2021-09-01)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
by: Martora F, et al.
Published: (2023-01-01)

Plasmablastic lymphoma masked by hidradenitis suppurativa
by: Sarah Preis, MD, et al.
Published: (2022-09-01)

Severe perineal hidradenitis suppurativa (HS) and anal fistulas. An underrated association?
by: Juan Carlos Bernal-Sprekelsen, et al.
Published: (2020-06-01)

A practical guide to starting a hidradenitis suppurativa specialty clinic
by: Terri Shih, BS, et al.
Published: (2023-06-01)

Real-world drug survival of patients with hidradenitis suppurativa treated with adalimumab
by: Ryan C. Saal, BS, et al.
Published: (2023-06-01)

Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study
by: Martina Burlando, et al.
Published: (2022-10-01)

Insights into New-onset Arthritis in Patients with Hidradenitis Suppurativa
by: Patricia Garbayo-Salmons, et al.
Published: (2024-06-01)

Determinants of appointment nonattendance among outpatients with hidradenitis suppurativa
by: Britt Nilausen, et al.
Published: (2024-03-01)

Certolizumab on treating hidradenitis suppurativa: a brief report
by: Asem Shadid, et al.
Published: (2022-10-01)

Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
by: Fabrizio Martora, et al.
Published: (2023-04-01)

Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
by: Fotiadou C, et al.
Published: (2016-10-01)

An Atlas of the Hidradenitis Suppurativa Transcriptome
by: Weronika Szukala, et al.
Published: (2024-01-01)

Hidradenitis suppurativa and psoriasis coexistence in patients with Down syndrome: A case series
by: Neslihan Demirel Öğüt, et al.
Published: (2022-09-01)

Polish guidelines for the diagnosis and treatment of hidradenitis suppurativa
by: Łukasz Matusiak, et al.
Published: (2024-06-01)

Sweet syndrome in a patient with Hidradenitis Suppurativa
by: Lakshay Jain, et al.
Published: (2020-04-01)

Use of botulinum toxin in hidradenitis suppurativa
by: Elcilane Gomes Silva, et al.
Published: (2021-12-01)

Hydroxychloroquine for the treatment of hidradenitis suppurativa
by: Elena Gonzalez Brant, MD, et al.
Published: (2023-07-01)

Hidradenitis suppurativa: A review of available immunotherapeutic agents and advancement in treatment
by: Ana Preda-Naumescu, et al.
Published: (2022-01-01)

Facklamia hominis in hidradenitis suppurativa
by: Yasmeen Basal, DO, et al.
Published: (2021-05-01)